Invention Grant
- Patent Title: Molecular methods for assessing urothelial disease
-
Application No.: US15756497Application Date: 2016-08-30
-
Publication No.: US11028443B2Publication Date: 2021-06-08
- Inventor: Taku Murakami , Cindy M. Yamamoto , Masato Mitsuhashi , Hiroshi Harada
- Applicant: Hitachi Chemical Co., Ltd. , Hitachi Chemical Co. America, Ltd. , City of Sapporo
- Applicant Address: JP Tokyo; US CA San Jose; JP Sapporo
- Assignee: Hitachi Chemical Co., Ltd.,Hitachi Chemical Co. America, Ltd.,City of Sapporo
- Current Assignee: Hitachi Chemical Co., Ltd.,Hitachi Chemical Co. America, Ltd.,City of Sapporo
- Current Assignee Address: JP Tokyo; US CA San Jose; JP Sapporo
- Agency: Knobbe Martens Olson & Bear LLP
- International Application: PCT/US2016/049483 WO 20160830
- International Announcement: WO2017/040520 WO 20170309
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886
Abstract:
The present disclosure relates to methods of collecting exosomes and microvesicles (EMV) from urine, isolating corresponding mRNA, and analyzing expression patterns in order to diagnose and treat various urothelial cancers. In particular, various expression patterns are analyzed through a unique diagnostic formula.
Public/Granted literature
- US20180327852A1 MOLECULAR METHODS FOR ASSESSING UROTHELIAL DISEASE Public/Granted day:2018-11-15
Information query
IPC分类:
